Dupont Capital Management Corp Vertex Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023
BUY
$314.42 - $351.91 $566,899 - $634,493
1,803 Added 69.27%
4,406 $1.55 Million
Q1 2023

Apr 28, 2023
SELL
$283.23 - $323.1 $374,430 - $427,138
-1,322 Reduced 33.68%
2,603 $820,000
Q4 2022

Jan 26, 2023
SELL
$285.76 - $321.48 $350,913 - $394,777
-1,228 Reduced 23.83%
3,925 $0
Q3 2022

Oct 31, 2022
BUY
$273.83 - $305.53 $34,228 - $38,191
125 Added 2.49%
5,153 $1.49 Million
Q2 2022

Jul 26, 2022
SELL
$234.96 - $292.55 $557,325 - $693,928
-2,372 Reduced 32.05%
5,028 $1.42 Million
Q1 2022

Apr 27, 2022
BUY
$221.42 - $260.97 $27,013 - $31,838
122 Added 1.68%
7,400 $1.93 Million
Q4 2021

Jan 31, 2022
BUY
$177.01 - $223.45 $147,095 - $185,686
831 Added 12.89%
7,278 $1.6 Million
Q3 2021

Nov 03, 2021
SELL
$181.39 - $202.99 $489,752 - $548,073
-2,700 Reduced 29.52%
6,447 $1.17 Million
Q2 2021

Jul 30, 2021
SELL
$187.49 - $221.1 $4.52 Million - $5.33 Million
-24,103 Reduced 72.49%
9,147 $1.84 Million
Q1 2021

Apr 29, 2021
SELL
$207.02 - $241.31 $1.67 Million - $1.94 Million
-8,058 Reduced 19.51%
33,250 $7.15 Million
Q4 2020

Jan 28, 2021
SELL
$207.01 - $276.09 $1.97 Million - $2.62 Million
-9,493 Reduced 18.69%
41,308 $9.76 Million
Q3 2020

Oct 29, 2020
SELL
$255.65 - $303.1 $823,959 - $976,891
-3,223 Reduced 5.97%
50,801 $13.8 Million
Q2 2020

Jul 24, 2020
BUY
$225.48 - $295.8 $767,984 - $1.01 Million
3,406 Added 6.73%
54,024 $15.7 Million
Q1 2020

Apr 29, 2020
BUY
$199.77 - $247.81 $1.3 Million - $1.61 Million
6,508 Added 14.75%
50,618 $12 Million
Q4 2019

Jan 27, 2020
BUY
$166.71 - $223.91 $92,690 - $124,493
556 Added 1.28%
44,110 $9.66 Million
Q3 2019

Oct 28, 2019
SELL
$166.23 - $187.09 $700,659 - $788,584
-4,215 Reduced 8.82%
43,554 $7.38 Million
Q2 2019

Jul 30, 2019
SELL
$164.61 - $190.37 $2.08 Million - $2.41 Million
-12,660 Reduced 20.95%
47,769 $8.76 Million
Q1 2019

Apr 30, 2019
SELL
$163.73 - $194.7 $791,634 - $941,374
-4,835 Reduced 7.41%
60,429 $11.1 Million
Q4 2018

Feb 01, 2019
BUY
$151.91 - $192.21 $140,212 - $177,409
923 Added 1.43%
65,264 $10.8 Million
Q3 2018

Nov 05, 2018
SELL
$167.73 - $192.74 $952,706 - $1.09 Million
-5,680 Reduced 8.11%
64,341 $12.4 Million
Q2 2018

Jul 30, 2018
BUY
$145.72 - $169.96 $4.52 Million - $5.28 Million
31,049 Added 79.67%
70,021 $11.9 Million
Q1 2018

May 02, 2018
SELL
$151.6 - $177.13 $1.09 Million - $1.28 Million
-7,199 Reduced 15.59%
38,972 $6.35 Million
Q4 2017

Jan 31, 2018
BUY
$137.28 - $155.55 $380,128 - $430,717
2,769 Added 6.38%
46,171 $6.92 Million
Q3 2017

Oct 31, 2017
BUY
$148.13 - $162.24 $6.43 Million - $7.04 Million
43,402
43,402 $6.6 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email